Gary R. Seabrook

Milwaukee VA Medical Center, Medical College of Wisconsin

Papers

4

Total Citations

58

H-Index

4

About

Gary R. Seabrook’s research focuses on the vascular mechanisms underlying atherosclerosis, particularly how cigarette smoke and hypercholesterolemia impair endothelial function. His most influential work, “Ascorbic Acid Prevents Cigarette Smoke Injury to Endothelium-Dependent Arterial Relaxation” (34 citations), demonstrated that antioxidant treatment can protect blood vessels from smoke-induced damage, highlighting oxidative stress as a key pathway. In related studies, he showed that combined exposure to smoke and high cholesterol synergistically worsens arterial relaxation (11 citations), while his 1998 paper on smoking cessation provided early evidence that endothelial dysfunction is reversible—a finding with direct clinical implications for cardiovascular risk reduction. Seabrook’s work, conducted primarily in rabbit models, helped establish the reversibility of smoke-induced vascular injury and the protective role of antioxidants. Though his citation counts are modest, his contributions are foundational to understanding how lifestyle factors and oxidative stress converge on the endothelium, offering a clear rationale for smoking cessation and antioxidant therapies in preventing atherosclerosis.

Research Focus

Key Achievements

4
H-Index
4
Papers
58
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Ascorbic Acid Prevents Cigarette Smoke Injury to Endothelium-Dependent Arterial Relaxation
34 citations · 1999
📈 Most Prolific Year: 1999 (2 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Milwaukee VA Medical Center, Medical College of Wisconsin

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago